Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Onyx Lotus LLC maintains a portfolio in the Biotechnology & Pharmaceuticals technology area characterized by a distributed prosecution load. With 3 pending office actions currently active, the company is engaged in multiple simultaneous negotiations with the patent office. These matters are spread across 3 distinct examiners, indicating that the company's legal strategy must account for the varying perspectives of several different officials. The involvement of 3 distinct art units further demonstrates that the underlying technologies span multiple specialized classifications within the patent office's organizational structure.
The busiest examiner identified in the data is BROWE, DAVID, who is currently handling 1 busiest examiner pending office action. This specific figure shows that while BROWE, DAVID is the most active individual, they only manage a portion of the 3 pending office actions total. For a patent practitioner, this distribution suggests that no single examiner holds a majority of the portfolio's pending matters. The parity between the 3 pending office actions and the 3 distinct examiners highlights an equal distribution of active cases to individual reviewers, requiring a broad approach to examiner engagement across the 3 distinct art units involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
| SMITH, NICHOLAS A | 1 | 63.5% | +31.7% |
| BROWE, DAVID | 1 | 26.4% | +27.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17888470 | METHODS OF SYNTHESIZING MULTI-METAL SALTS COMPOSITION | SMITH, NICHOLAS A | 42d overdue |
| 17888473 | MULTI-METAL SALTS DISINFECTANT COMPOSITION | JANOSKO, CHASITY PAIGE | — |
| 17888469 | LIGHT STABLE LIQUID DISINFECTANT COMPOSITIONS | BROWE, DAVID | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17888470 | METHODS OF SYNTHESIZING MULTI-METAL SALTS COMPOSITION | SMITH, NICHOLAS A | 42d overdue |
| 17888473 | MULTI-METAL SALTS DISINFECTANT COMPOSITION | JANOSKO, CHASITY PAIGE | — |
| 17888469 | LIGHT STABLE LIQUID DISINFECTANT COMPOSITIONS | BROWE, DAVID | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1752 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17888473 | MULTI-METAL SALTS DISINFECTANT COMPOSITION | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | — | Pending | Aug 15, 2022 |
| 17888470 | METHODS OF SYNTHESIZING MULTI-METAL SALTS COMPOSITION | SMITH, NICHOLAS A | 1752 | §103§112 | Non-Final OA | 42d overdue | Pending | Aug 15, 2022 |
| 17888469 | LIGHT STABLE LIQUID DISINFECTANT COMPOSITIONS | BROWE, DAVID | 1617 | §103§112 | Non-Final OA | — | Pending | Aug 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial